The effect of prolonged aflatoxin B 1 (AFB 1 ) administration on blood serum oestradiol-17β and progesterone concentrations in goats during the anoestrus period was investigated. Thirty Greek indigenous goats were used; 10 goats received, per os, 50 μg (treated group T50) and 10 goats received 100 μg (treated group T100) AFB 1 /day/head, respectively, for 31 days, while 10 goats served as controls (C). Blood samples were collected from each goat twice a week to determine serum oestradiol-17β and progesterone concentrations by radioimmunoassay. Multiple linear regression analysis revealed a significant (P < 0.05) positive dependence of blood serum oestradiol-17β concentration over group (C = 0, T50 = 50, T100 = 100), in a dosedependent manner, and a significant (P < 0.05) negative dependence over time (0-31 days, from the onset to the end of AFB 1 administration). Linear regression analysis revealed a significant (P < 0.05) positive dependence of blood serum progesterone concentration over group (C = 0, T50 = 50, T100 = 100), in a dose-dependent manner. Pearson's correlation coefficient revealed a significant (P < 0.05) positive correlation between blood serum oestradiol-17β and progesterone concentration, but only in the goats of the control group. In conclusion, the prolonged administration of 100 or even of 50 μg AFB 1 /day/head during the anoestrus period, increased blood serum oestradiol-17β and progesterone concentrations of goats, in a dose-dependent manner, and in the treated groups disturbed the positive correlation between oestradiol-17β and progesterone concentration shown in the goats of the control group.
INTRODUCTION
Aflatoxins (B 1 , B 2 , G 1 , and G 2 ) are toxic metabolites, with carcinogenic potency, of the fungi Aspergillus flavus and Aspergillus parasiticus. These fungi invade the forages and under suitable conditions produce aflatoxins (Thieu et al. 2008 ).
The consumption of aflatoxins by animals or human results in various pathological conditions (aflatoxicoses), with symptoms that vary depending on the species, age, degree of forage invasion by the fungi, and quantity of the consumed feeds or food (Diekman and Green 1992) . The regions more affected by aflatoxins are those with tropic or doi: 10.17221/8130-CJAS subtropic climate, since the levels of humidity and temperature play a positive role in fungal growth (Galvano et al. 1996; Abdulrazzaq et al. 2003) . The consumption of AFB 1 results in the excretion of aflatoxin M 1 into the milk. Aflatoxin M 1 is the major of AFB 1 metabolites, mainly produced in the liver, with carcinogenic potency as well, and in some cases it is detected at concentrations higher than the maximum permissible levels fixed by each country, making the milk inappropriate for consumption (El-Nezami et al. 1995; Abdulrazzaq et al. 2003; Kourousekos et al. 2012) .
Regarding the reproductive system, the mechanisms through which it is affected by AFB 1 remain unexplained, since the effects of the toxin have not been studied extensively (Shuaib et al. 2010) . Concerning the male reproductive system, most reports are related with the negative effect of AFB 1 οn the size and weight of genital organs, οn spermatogenesis (Gopal et al. 1980) , οn the number and morphology of spermatozoa (Hafez et al. 1982; Ortatatli et al. 2002; Agnes and Akbarsha 2003) , and οn blood oestrogens and testosterone concentrations (Gopal et al. 1980; Verma and Nair 2002) .
Regarding the female reproductive system, inhibition of sexual maturation (Doerr and Ottinger 1980) , libido, growth and maturation of follicles, foetus growth (Schmidt and Panciera 1980; Ibeh and Saxena 1997a, b; Wangikar et al. 2005) , reduction of sex organs weight, as well as increased blood progesterone and decreased oestradiol concentrations during oestrus and decrease in maternal oestradiol : progesterone ratio (Ibeh and Saxena 1997a, b) were observed after AFB 1 administration.
Moreover, the high risk of toxicity of AFB 1 to the foetus and placenta due to aflatoxicol production, AFB 1 metabolite with carcinogenic potency as well, was studied in women (Partanen et al. 2010) . The risk was found to be more serious in high-risk countries, such as Egypt (Piekkola et al. 2012) . Furthermore, Storvik et al. (2011) indicated that chronic exposure to AFB 1 might cause endocrine disruption in the human foetoplacental unit due to its effect on the expression of aromatase enzymes (P450s or CYPs enzymes), categorizing AFB 1 as a potential endocrine disruptor.
Studies dealing with the effects of AFB 1 administration on the reproductive system of farm animals are limited. Moreover, these studies, mainly in laboratory animals, use quite higher concentrations and/or shorter periods of AFB 1 administration.
Thus the aim of the present study was to investigate, for the first time, possible alterations in blood serum oestradiol-17β and progesterone concentrations of goats after prolonged AFB 1 administration (31 days) during the anoestrus period, since anoestrus period in seasonally polyoestrous animals like goats is characterized by the absence of cyclic ovarian activity and oestrous behaviour due to the low control of the hypothalamus-hypophysis axe at the ovaries. o C, average humidity 53.0%; 14.5 h day-light + 9.5 h darkness). All the goats performed parturition about four months ago without their oestrus cycles previously being synchronized. Throughout the experimental period, the goats were not in contact with other animals, they were healthy, without any pharmaceutical treatment. The goats were fed 1 kg/ day/head of pelleted concentrate plus grass hay ad libitum; water was available for the animals 24 hours a day. The pelleted concentrate feed consisted of corn, barley, gluten, soybean meal, molasses, yeast ranching, sodium chloride, calcium carbonate, dicalcium phosphate, vegetable fat, vitamins, and minerals. The chemical analysis of the pelleted concentrate feed was (in %): dry matter 52.4, total proteins 17.2, fat 3.3, cellulose 3.9, ashes 7.7, moisture 13.0, calcium 1.2, phosphorus 0.7, sodium 0.6, and chlorine 0.04.
MATERIAL AND METHODS
To ensure that the goats did not receive any AFB 1 concentrations through their diet, feedstuff samples were analyzed, once a week, for AFB 1 presence using high performance liquid chromatography (HPLC), as described by Akiyama et al. (2001) with the assistance of specific columns (MycoSep ® 226 columns for AFB 1 ). The minimum detection limit for AFB 1 was 0.5 ppb. None of the samples was found positive for AFB 1 presence. Moreover, the body weight of all goats was measured once a week. No significant differences (P > 0.05) were observed during the whole experimental period.
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Goats were randomly divided into 3 groups of 10 animals each (control group (C), treated group (T50), and treated group (T100)). The goats of T50 or T100 treated groups received 50 or 100 μg AFB 1 /day/head), per os, respectively, for 31 days. These doses were based on the results of a previous study, where the administration of such AFB 1 doses to Greek indigenous goats resulted in the excretion of aflatoxin M 1 into the milk, exceeding the maximum permissible level (50 ppt) set by the European Union (Kourousekos et al. 2012) . Ten mg of pure AFB 1 (AFB 1 from Aspergillus flavus, A 6636-10 MG, SIGMA; Sigma Chemical Co., St. Louis, USA) were dissolved in 100 ml methanol or in 200 ml methanol and 1 ml of this dilution was received per os by each goat of T50 or T100 treated groups, respectively. The goats of the control group received only the solvent of AFB 1 (1 ml methanol/day) in order to be equally handled; according to Battacone et al. (2003) methanol is the best solvent for AFB 1 for in vivo treatment, while the administration of methanol at these concentrations has no risk for the animal's health (http://www.epa.gov/chemfact/s_methan.txt). Administration of diluted AFB 1 to goats of T50 or T100 treated groups, as well as of 1 ml methanol to goats of the control group, was achieved using a dosimetric pistollete-like pump in order to be controlled and easily accepted. The administration to all animals was realized the same hour (7:00 h) each morning.
Blood samples were collected from the onset to the end of AFB 1 administration, twice a week, from each goat (always on the same days and the same time at about 8:00 h). Additionally, before the onset of AFB 1 administration, four blood samples had been collected from each goat, in a two-week period, by jugular venipuncture into evacuated blood collecting tubes (Venoject, Terumo, Belgium). After clotting, blood samples were centrifuged (2500 g; 20 min; 4°C); serum was aspirated and stored at -20°C until assayed.
Oestradiol-17β and progesterone assays. Oestradiol-17β and progesterone concentrations in blood serum were determined using radioimmunoassay (RIA), after extraction, as described by Martin et al. (1987) , following minor modification (Rekkas et al. 1991) . The radiolabelled solutions of oestradiol-17β and progesterone were provided by Amersham Pharmacia Biotech (Amersham, UK), while oestradiol-17β and progesterone antiserums were developed by the Institute of Molecular Biology, Iraklion, Greece (Theodosiadou et al. 2004 ). The intra-assay variability was 3.5-5.5% (n = 6) and 2.4-4.4% (n = 6), while the inter-assay variability was 9.2% (n = 24) and 9.4% (n = 24) for oestradiol-17β and progesterone, respectively. The recovery rate was 93.3 ± 2.8% (mean ± SD; n = 24) for oestradiol-17β and 94.5 ± 2.2% (mean ± SD; n = 24) for progesterone. The sensitivity (lower limit of detection) for oestradiol-17β was 3.90 pg/ml, while for progesterone it was 19 pg/ml (0.019 ng/ml).
Statistical analysis. One-way analysis of variance (one-way ANOVA) was used to compare oestradiol-17β or progesterone concentrations among the three groups studied. Levene's test was used for the control of homogeneity of variances and statistical differences were estimated using Tukey's HSD test. Linear regression analysis was used in order to trace the variability of oestradiol-17β or progesterone concentration over group (C = 0, T50 = 50, T100 = 100) and over time (0-31 days, from the onset to the end of AFB 1 administration) (multiple), or over group, or over time. Pearson's correlation coefficient was used in order to correlate oestradiol-17β and progesterone concentration in each group studied. Linear regression analysis was used in order to describe the significant equation. Statistical analysis was performed using SPSS software (Version 15.0, 2006) for MS Windows and a probability of P < 0.05 was the minimum level of significance, in all cases.
RESULTS
Before AFB 1 administration no significant differences (P > 0.05) were observed among the three groups studied regarding blood serum oestradiol-17β ((C = 45.08 ± 9.99; T50 = 45.09 ± 9.46; T100 = 48.80 ± 9.52) or progesterone concentration (C = 0.20 ± 0.07; T50 = 0.20 ± 0.09; T100 = 0.21 ± 0.07) (mean ± SD, n = 40)).
After AFB 1 administration, blood serum oestradiol-17β or progesterone concentrations of the goats of the treated groups T50 or T100 presented significantly higher (P < 0.05) than those of the goats of group C; the significantly highest (P < 0.05) concentration was observed in T100 group. Analytically, the first 3 days after AFB 1 administration, oestradiol-17β or progesterone concentration showed no significant differences (P > 0.05) between the three groups studied. From 7 to 14 days doi: 10.17221/8130-CJAS after AFB 1 administration group T100 showed significantly (P < 0.05) higher oestradiol-17β or progesterone concentration compared to T50 or C group, while no significant difference (P > 0.05) was observed between T50 and C group. From day 17 to the end of AFB 1 administration (day 31) either T50 or T100 group showed significantly (P < 0.05) higher oestradiol-17β or progesterone concentration than group C, while the significantly (P < 0.05) highest concentration was observed in T100 group (Figures 1 and 2 ).
More specifically, multiple linear regression analysis revealed a significant dose-dependent increase of blood serum oestradiol-17β concentration over group and a significant decrease over time (F = 190.94 , df = 297, P < 0.000; constant = 41.06 ± 1.01, t = 40.63, P = 7.83E-021; Group = 0.12 ± 0.01, t = 10.85, P = 7.83E-021; Time = -0.74 ± 0.05, t = -16.25, P = 7.83E-021).
Also, linear regression analysis revealed a significant dose-dependent increase of blood serum progesterone concentration over group (F = 64.93, df = 298, P = 1.82E-014; constant = 0.16 ± 0.004, t = 42.60, P = 7.72E-021; Group = 4.80E-04 ± 5.90E-05, t = 8.06, P = 1.82E-014).
Finally, a significant positive correlation between blood serum oestradiol-17β and progesterone concentration was revealed, but only in the goats of the control group (Pearson's coefficient = 0.267; n = 100; P = 0.007). The significant positive equation, according to linear regression analysis results, for blood serum oestradiol-17β was (F = 7.52, df = 98, P = 0.007; constant = 16.14 ± 5.18, t = 3.12, P = 0.002; progesterone = 84.96 ± 30.98, t = 2.74, P = 0.007), while for blood serum progesterone was (F = 7.52, df = 98, P = 0.007; constant = 0.14 ± 0.01, t = 13.97, P = 1.10E-018; oestradiol-17β = 8.39E-04 ± 3.10E-04, t = 2.74, P = 0.007).
This correlation disappeared in the goats of T50 group (Pearson's coefficient = 0.136, n = 100, P = 0.177) or T100 group (Pearson's coefficient = -0.123, n = 100, P = 0.223).
DISCUSSION
In the present study, the prolonged administration of 100 or even of 50 μg AFB 1 /day/head, during the anoestrus period, increased blood serum oestradiol-17β and progesterone concentrations of the goats, in a dose-dependent manner, and in the treated groups (T50 or T100) disturbed the positive correlation between oestradiol-17β and progesterone concentration shown in the goats of the control group.
Greek indigenous goats are considered to be late-seasoned animals presenting oestrus cycles from the end of August, even middle of September (a strong variability between breeds exists in goats Figure 2 . Progesterone concentration (ng/ml) in blood serum of goats, from the onset to the end of AFB 1 administration (0-31 days), during the anoestrus period (control group (C); treated group T50 (50 μg AFB 1 /goat/day); treated group T100 (100 μg AFB 1 /goat/day)) a-c significant differences between the three groups at each time point studied (P < 0.05) Figure 1 . Oestradiol-17β concentration (pg/ml) in blood serum of goats, from the onset to the end of AFB 1 administration (0-31 days), during the anoestrus period (control group (C); treated group T50 (50 μg AFB 1 /goat/day); treated group T100 (100 μg AFB 1 /goat/day)) a-c significant differences between the three groups at each time point studied (P < 0.05) doi: 10.17221/8130-CJAS regarding the dates of onset of the breeding season, with a gradient of seasonality from southern to northern latitudes (Chemineau et al. 2010; Fatet et al. 2011) ). In the present study progesterone and oestradiol-17β concentrations during the anoestrus period (middle of June until middle of July) were in accordance with those in the study of Goulas (1993) in Greek indigenous goats as well as of Yuthasastrakosol et al. (1975) and Haresign et al. (1975) in ewes, although increased in groups receiving AFB 1 , in a dose-dependent manner, compared to control group. The minor fluctuations shown in our study concerning oestradiol-17β or progesterone concentration, as well as the minor peak in progesterone concentration might reflect fluctuations of LH shown close to the end of the anoestrus period that might prepare the ovaries for the oestrus period, as Yuthasastrakosol et al. (1975) supported in ewes.
Other researchers also confirm disturbances on reproductive performance due to AFB 1 administration, in a dose-dependent manner, but during the oestrus period. Ibeh and Saxena (1997a, b) in female rats administered 7.5 mg AFB 1 /kg body weight per day for 14 days or 15 mg AFB 1 /kg body weight per day for 21 days, respectively, and observed that body, ovaries, and uterus weights were significantly decreased. Inhibition of libido, oocytes growth, and number of ovulations, as well as high percentage of foetal deaths and decrease in maternal oestradiol : progesterone ratio was also observed. Oestradiol and progesterone concentrations appeared significantly lower and higher, respectively, in rats receiving AFB 1 . After prolonged AFB 1 administration but also during the oestrus period of the Greek indigenous goats, increased progesterone concentrations during the luteal phase and decreased oestradiol-17β concentrations during oestrous synchronization were also confirmed by Kourousekos et al. (2008) . In order to explain these hormones disturbances, the authors proposed either a direct effect of AFB 1 on ovarian secreting cells or on the hypothalamushypophysis-ovaries axis.
The possible direct effect of AFB 1 on testes was supported by Gopal et al. (1980) and Verma and Nair (2002) . Gopal et al. (1980) injected intratesticularly AFB 1 in male rats at doses of 5, 10, 25, and 50 μg for 11 days. Blood oestrogen concentrations were found significantly lower, while spermatogenesis was inhibited. Moreover, Verma and Nair (2002) supported that the reduced testosterone concentration after oral AFB 1 administration (25 and 50 μg/ day/animal for 45 days) in adult male mice was attributed to mitochondria dysfunction, to inhibition in protein synthesis or enzyme activity or to membrane changes of Leydig cells. In the present study, the prolonged AFB 1 administration could have directly affected the ovaries and because of one of the mechanisms above could have increased oestradiol-17β and progesterone concentrations and could have disturbed in both the treated groups the positive correlation between them shown in the goats of the control group.
In order to explain the aflatoxins actions, a lot of years ago some researchers considered the likely binding of the oestrogen receptors by aflatoxins, but this assumption seems not to be in issue. Kyrein (1974) observed that aflatoxins B 1 , G 1, and G 2 did not present any binding affinity to oestrogen receptors derived from healthy uterus of calves, although aflatoxin M 1 presented a small extent of receptors binding, but in quite higher concentrations compared with oestradiol-17β. Moreover, no binding affinity was observed for AFB 1 or aflatoxin M 1 to oestrogen or progesterone receptors of cow uterus (Blankenship et al. 1982) , while aflatoxicol showed a small binding affinity, but only to oestrogen receptors.
Recently, AFB 1 has been categorized as a potential endocrine disruptor (Storvik et al. 2011) . It is known that AFB 1 is metabolized by cytochrome P450 (CYPs) enzymes (Buhler and Wang-Buhler 1998) . Furthermore, Storvik et al. (2011) and Huuskonen et al. (2013) supported that AFB 1 increases the expression of CYP19A1 in human placenta cells. More specifically, Huuskonen et al. (2013) indicated that AFB 1 affected the placental steroid hormone synthesizing, metabolizing, and conjugating enzymes and that these alterations may lead to anomalies in the foetoplacental hormonal homeostasis, while Storvik et al. (2011) suggested that AFB 1 , after being metabolized in aflatoxicol, had effects on genes important for endocrine regulation in placental cells. Furthermore, since CYPs have been found to take part in steroid hormones synthesis, the increase of the expression of such enzyme by AFB 1 in the placenta could result in increased oestrogen and progesterone production. In our study the increased blood serum oestradiol-17β and progesterone concentration, in a dose-dependent manner, in the goats of either doi: 10.17221/8130-CJAS T50 or T100 group might have been a result of such an increased expression of CYPs enzymes on the ovaries due to prolonged administration of AFB 1 .
The increased progesterone and oestradiol-17β concentration close to the end of the anoestrus period in goats under the prolonged administration of AFB 1 , in a dose-dependent manner, compared to control goats, as well as the disappearance in the treated groups of the positive correlation between oestradiol-17β and progesterone concentration shown in the control group, might reflect disturbances at the reproductive system of the goats coming close to their oestrus period. Further research is needed in order to investigate the effects of AFB 1 prolonged administration on the onset and duration of the oestrus period or on the onset and duration of the first oestrus.
CONCLUSION
Conclusively, the long-lasting administration (31 days) of 100 or even of 50 μg AFB 1 /day/head increases, in a dose-dependent manner, blood serum oestradiol-17β and progesterone concentrations in Greek indigenous goats and in the treated groups disturbs the positive correlation between oestradiol-17β and progesterone concentration shown in the goats of the control group during the anoestrus period. These results that might be produced by disturbances in the synthesis and production of ovarian steroids due to the direct effect of AFB 1 at the ovaries might reflect disturbances in the reproductive system of goats coming close to their oestrus period.
